Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

The peripheral NK-1/NK-2 receptor antagonist MDL 105,172A inhibits tachykinin-mediated respiratory effects in guinea-pigs.

Kudlacz EM, Knippenberg RW, Shatzer SA, Kehne JH, McCloskey TC, Burkholder TP.

J Auton Pharmacol. 1997 Apr;17(2):109-19.

PMID:
9234081
2.

Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model.

Kudlacz EM, Knippenberg RW, Logan DE, Burkholder TP.

J Pharmacol Exp Ther. 1996 Nov;279(2):732-9.

PMID:
8930178
3.

In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.

Kudlacz EM, Shatzer SA, Knippenberg RW, Logan DE, Poirot M, van Giersbergen PL, Burkholder TP.

J Pharmacol Exp Ther. 1996 May;277(2):840-51.

PMID:
8627566
4.
5.

In vitro and in vivo effects of tachykinins on immune cell function in guinea pig airways.

Kudlacz EM, Knippenberg RW.

J Neuroimmunol. 1994 Mar;50(2):119-25.

PMID:
8120132
7.
8.
9.

Temporal relationships among immunologic alterations in a guinea pig model of thermal injury.

Bjornson AB, Bjornson HS, Knippenberg RW, Cardone JS.

J Infect Dis. 1986 Jun;153(6):1098-107.

PMID:
3084670

Supplemental Content

Loading ...
Support Center